|Bid||54.39 x 900|
|Ask||54.30 x 800|
|Day's range||54.24 - 56.62|
|52-week range||54.24 - 93.32|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||6,033.33|
|Earnings date||06 Dec 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||83.50|
HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HealthEquity (HQY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
DRAPER, Utah, Nov. 10, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced plans to release its third quarter of fiscal 2022 financial results following the close of regular stock market trading hours on Monday, December 6, 2021. Following the news release, HealthEquity management plans to host a conference call for investors on Monday, December 6, 2021, at 4:30 pm ET during which management will revi